《Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review》, JOHMPE, 卷 3, 期 1, 2月 2025, doi: 10.52465/johmpe.v3i1.547.